doi:10.3969/j.issn.1673-8640.2021.09.009

Abstract

CLC Number:

R446.1

Figures/Tables 3

References 10

[1]	熊崇呈. 脓毒症休克早期目标导向治疗的再评价及研究进展[J]. 中国处方药, 2019, 17(12):13-14.
[2]	中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 临床急诊杂志, 2018, 19(9):567-588.
[3]	符秋红. 血乳酸、C-反应蛋白及红细胞分布宽度早期动态监测在危重病的应用研究[J]. 中国医学工程, 2017, 25(2):8-10.
[4]	高戈, 冯喆, 常志刚, 等. 2012国际严重脓毒症及脓毒性休克诊疗指南[J]. 中华危重病急救医学, 2013, 25(8):501-505.
[5]	付跃峰, 孔令博, 郭楠, 等. 老年脓毒症休克的中西医结合救治体会[J]. 中国医药导报, 2019, 16(9):127-130.
[6]	干浩庆, 张海光. 老年脓毒症休克患者血清氨基末端脑钠肽前体、肌钙蛋白I水平及其与预后的相关性[J]. 中国老年学杂志, 2019, 39(23):5760-5762.
[7]	胡昊昀, 周磊, 高翔, 等. C反应蛋白在肿瘤患者感染的诊断和病情监测中的价值[J]. 检验医学, 2016, 31(4):253-257.
[8]	王春源, 曹涛, 勤俭. 早期心肌肌钙蛋白I及乳酸水平联合检测对急诊老年严重脓毒症及脓毒症休克患者预后的评估价值[J]. 实用临床医药杂志, 2017, 21(9):61-63.
[9]	贾凯剑, 郭任维, 李莉. 红细胞分布宽度在心力衰竭中应用的研究进展[J]. 中国医学创新, 2019, 16(7):165-168.
[10]	宋小莉, 苏娟. 红细胞分布宽度在自身免疫性疾病中的研究进展[J]. 中国全科医学, 2017, 20(35):4459-4463.

组别	例数	Lac/（mmol/L）	RDW/%	CRP/（mg/L）	PCT/（ng/mL）	APACHE Ⅱ评分/分	SOFA评分/分
健康对照组	90	1.06±0.21	10.16±1.38	3.01±0.51	0.22±0.05
未休克组	50	1.77±0.32^*	13.29±0.17^*	91.24±4.33^*	5.92±1.02^*	12.33±2.41	5.05±1.00
休克组	40	3.95±0.24^*#	16.54±1.99^*#	152.76±2.42^*#	15.03±1.88^*#	24.67±3.09	10.08±2.16
统计值		1 782.634	409.437	77 423.055	2 089.713	-20.372	-13.255
P值		0.000	0.000	0.000	0.000	0.000	0.000

组别	例数	Lac/（mmol/L）	RDW/%	CRP/（mg/L）	PCT/（ng/mL）	APACHE Ⅱ评分/分	SOFA评分/分
健康对照组	90	1.06±0.21	10.16±1.38	3.01±0.51	0.22±0.05
未休克组	50	1.77±0.32^*	13.29±0.17^*	91.24±4.33^*	5.92±1.02^*	12.33±2.41	5.05±1.00
休克组	40	3.95±0.24^*#	16.54±1.99^*#	152.76±2.42^*#	15.03±1.88^*#	24.67±3.09	10.08±2.16
统计值		1 782.634	409.437	77 423.055	2 089.713	-20.372	-13.255
P值		0.000	0.000	0.000	0.000	0.000	0.000

组别	例数	Lac/（mmol/L）	RDW/%	CRP/（mg/L）	PCT/（ng/mL）	APACHE Ⅱ评分/分	SOFA评分/分
存活组	28	2.78±0.56	14.89±2.61	115.23±8.44	11.03±1.99	17.33±4.15	5.11±1.20
死亡组	12	5.09±1.33	18.15±3.22	190.01±7.26	19.02±2.02	32.01±6.34	15.08±1.82
t值		-6.923	-3.322	-24.328	-12.445	-11.424	-26.151
P值		0.000	0.000	0.000	0.000	0.000	0.000

组别	例数	Lac/（mmol/L）	RDW/%	CRP/（mg/L）	PCT/（ng/mL）	APACHE Ⅱ评分/分	SOFA评分/分
存活组	28	2.78±0.56	14.89±2.61	115.23±8.44	11.03±1.99	17.33±4.15	5.11±1.20
死亡组	12	5.09±1.33	18.15±3.22	190.01±7.26	19.02±2.02	32.01±6.34	15.08±1.82
t值		-6.923	-3.322	-24.328	-12.445	-11.424	-26.151
P值		0.000	0.000	0.000	0.000	0.000	0.000

预后指标	Lac		RDW
预后指标	r值	P值	r值	P值
CRP	0.446	0.004	0.379	0.016
PCT	0.707	0.000	0.599	0.000
APACHE Ⅱ评分	0.489	0.001	0.382	0.015
SOFA评分	0.588	0.000	0.393	0.012

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 10

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.